INS and Parkinson disease: There are several promising anti-PD therapies in development to help ameliorate motor symptoms and overcome the loss of dopamine, including stem cell therapies, adenoviral administration of neurotrophic agents, intranasal administration of insulin, mitochondrial-targeted antioxidants (e.g., MitoQ) and intranasal formulations of Metformin.